Vaculitis bilateral, management
vasculitis lower limb bilateral management treatment
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 12739
Buerger's disease thromboangiitis obliterans vasculitis treatment cilostazol
Bailey and Love's Short Practice of Surgery 28th Edition
Page 1045
| Parameter | Left | Right |
|---|---|---|
| Normal CAS | — | — |
| DP (Dorsalis Pedis) | Absent | Absent |
| PT (Posterior Tibial) | Normal | Normal |
| Pop (Popliteal) | Normal | Normal |
| Fem (Femoral) | Normal | Normal |
Absent DP pulses bilaterally with preserved proximal flow suggests distal small vessel vasculitis — consistent with Buerger's disease (Thromboangiitis Obliterans) pattern in a young patient, or systemic small vessel vasculitis.
| # | Drug | Dose | Frequency | Purpose |
|---|---|---|---|---|
| 1 | T. Rosuvas / Rosuvastatin | 2.5 mg | 9am + 7pm | Vascular inflammation, dyslipidemia |
| 2 | T. Roverstat-A (Rosuvastatin + Aspirin) | 75/20 mg | 2pm | Antiplatelet + statin |
| 3 | T. Pletodol / Cilostazol | 50 mg | 9am + 7pm | Vasodilator, antiplatelet for claudication |
| 4 | Cap. Dobesilate (Calcium Dobesilate) | 500 mg | Once daily | Capillary stabilizer, microangiopathy |
| 5 | Cap. CoEnzyme Q10 | 10 mg | Once daily | Antioxidant, vascular support |
| 6 | T. Reno-MNP (Modified-release Isosorbide Mononitrate) | — | 7pm | Vasodilator |
| 7 | T. Homostron Forte | — | 6pm | Likely analgesic/supportive |